During the 8th Microbiome Movement – Drug Development Summit, held in London at the end of January, MicrobiomePost discussed with Gabriel Leventhal, Chief Scientific Officer at Pharmabiome, about NicheMap, a reference database that allows us to interpret compositional data on a niche-interaction level and select the most appropriate strains to engineer targeted changes in the microbiome.